YAP is a candidate oncogene for esophageal squamous cell carcinoma

Carcinogenesis

Volumn 32, Issue 3, 2011, Pages 389-398

  Muramatsu, Tomoki ^a   Imoto, Issei ^a,b   Matsui, Takeshi ^a   Kozaki, Ken Ichi ^a   Haruki, Shigeo ^a   Sudol, Marius ^c   Shimada, Yutaka ^d   Tsuda, Hitoshi ^a,e   Kawano, Tatsuyuki ^a   Inazawa, Johji ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c WEIS CENTER FOR RESEARCH   (United States)

^d UNIVERSITY OF TOYAMA   (Japan)

^e NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; ONCOPROTEIN; PROTEIN P21; SURVIVIN; UNCLASSIFIED DRUG; YES ASSOCIATED PROTEIN;

ADULT; AMPLICON; ARTICLE; CARCINOGENESIS; CARCINOMA CELL; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CHROMOSOME 11; CHROMOSOME 11Q; CONTROLLED STUDY; EMBRYONIC STEM CELL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE AMPLIFICATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NUCLEOTIDE SEQUENCE; ONCOGENE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN TARGETING; WESTERN BLOTTING;

EID: 79952304497     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq254     Document Type: Article

References (38)

1. Harvey, K. et al. (2007) The Salvador-Warts-Hippo pathway: an emerging tumor-suppressor network. Nat. Rev. Cancer, 7, 182-191.
2. Zhao, B. et al. (2008) TEAD mediates YAP-dependent gene induction and growth control. Genes Dev., 22, 1962-1971.
3. Morin-Kensicki, E.M. et al. (2006) Defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65. Mol. Cell. Biol., 26, 77-87.
4. Strano, S. et al. (2001) Physical interaction with Yes-associated protein enhances p73 transcriptional activity. J. Biol. Chem., 276, 15164-15173.
5. Matallanas, D. et al. (2007) RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. Mol. Cell, 27, 962-975.
6. Danovi, S.A. et al. (2008) Yes-associated protein (YAP) is a critical mediator of c-Jun-dependent apoptosis. Cell Death Differ., 15, 217-219.
7. Lapi, E. et al. (2008) PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop. Mol. Cell, 32, 803-814.
8. Oka, T. et al. (2008) Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP). J. Biol. Chem., 283, 27534-27546.
9. Yuan, M. et al. (2008) Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death Differ., 15, 1752-1759.
10. Lam-Himlin, D. M. et al. (2006) The hippo pathway in human upper gastrointestinal dysplasia and carcinoma: a novel oncogenic pathway. Int. J. Gastrointest. Cancer, 37, 103-109.
11. Overholtzer, M. et al. (2006) Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc. Natl Acad. Sci. USA, 103, 12405-124010.
12. Zender, L. et al. (2006) Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell, 125, 1253-1267.
13. Dong, J. et al. (2007) Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell, 130, 1120-1133.
14. Steinhardt, A.A. et al. (2008) Expression of Yes-associated protein in common solid tumors. Hum. Pathol., 39, 1582-1589.
15. Da, C.L. et al. (2009) Significance and relationship between Yes-associated protein and survivin expression in gastric carcinoma and precancerous lesions. World J. Gastroenterol., 15, 4055-4061.
16. Fernandez-L, A. et al. (2009) YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. Genes Dev., 23, 2729-2741.
17. Camargo, F.D. et al. (2007) YAP1 increases organ size and expands undifferentiated progenitor cells. Curr. Biol., 17, 2054-2060.
18. Zhao, B. et al. (2007) Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev., 21, 2747-2761.
19. Bertini, E. et al. (2009) YAP at the crossroad between transformation and tumor suppression. Cell Cycle, 8, 49-57.
20. Parkin, D.M. et al. (2005) Global cancer Statistics, 2002. CA Cancer J. Clin., 55, 74-108.
21. Lam, A.K. (2000) Molecular biology of esophageal squamous cell carcinoma. Crit. Rev. Oncol. Hematol., 33, 71-90.
22. Imoto, I. et al. (2001) Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas. Cancer Res., 61, 6629-6634.
23. Komatsu, S. et al. (2009) Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma. Carcinogenesis, 30, 1139-1146.
24. Naoi, Y. et al. (2008) Connexin26 expression is associated with aggressive phenotype in human papillary and follicular thyroid cancers. Cancer Lett., 268, 248-256.
25. Sudol, M. et al. (1995) Characterization of the mammalian YAP (Yesassociated Protein) gene and Its role in defining a novel protein module, the WW Domain. J. Biol. Chem., 270, 14733-14741.
26. Komuro, A. et al. (2003) WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxy-terminal fragment of ErbB4 that translocates to the nucleus. J. Biol. Chem., 278, 33334-33341.
27. Vitolo, M.I. et al. (2007) The RUNX2 transcription factor cooperates with the YES-associated protein, YAP65, to promote cell transformation. Cancer Biol. Ther., 6, 856-863.
28. Löhr, K. et al. (2003) p21/CDKN1A mediates negative regulation of transcription by p53. J. Biol. Chem., 278, 32507-32516.
29. Zhao, B. et al. (2010) The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev., 24, 862-874.
30. Baldwin, C. et al. (2005) Multiple microalterations detected at high frequency in oral cancer. Cancer Res., 65, 7561-7567.
31. Snijders, A.M. et al. (2005) Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene, 24, 4232-4242.
32. Modena, P. et al. (2006) Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. J. Clin. Oncol., 24, 5223-5233.
33. Xu, M.Z. et al. (2009) Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer, 115, 4576-4585.
34. Wang, Y. et al. (2010) Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer. Cancer Sci., 101, 1279-1285.
35. Sudol, M. et al. (2010) Modularity in the Hippo signaling pathway. Trends Biochem. Sci., 35, 627-633.
36. Ota, M. et al. (2008) Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling. Development, 135, 4059-4069.
37. Sawada, A. et al. (2008) Redundant roles of Tead1 and Tead2 in notochord development and the regulation of cell proliferation and survival. Mol. Cell. Biol., 28, 3177-3189.
38. Huang, J. et al. (2005) The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP. Cell, 122, 421-434.